We are live on
!
Find out more
EEG
E.E. Geduld Portfolio holdings
AUM
$178M
1-Year Est. Return
29.34%
This Fund
S&P 500
This Quarter
Est. Return
+6.08%
1 Year Est. Return
+29.34%
3 Year Est. Return
+59.91%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$161M
AUM Growth
+$11M
(+7.3%)
Cap. Flow
-$5.71M
Cap. Flow
% of AUM
-3.55%
Top 10 Holdings %
Top 10 Hldgs %
44.28%
Holding
361
New
80
Increased
31
Reduced
55
Closed
58
Avg Time Held Equity + Options
3.6
quarters
Top 10 Avg Time Held Equity + Options
2.1
quarters
Top 20 Avg Time Held Equity + Options
2.3
quarters
Avg Time Held Equity only
3.9
quarters
Top 10 Avg Time Held Equity only
3.5
quarters
Top 20 Avg Time Held Equity only
3.3
quarters
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Capri Holdings
CPRI
|
+$1.13M |
| 2 |
Biogen
BIIB
|
+$803K |
| 3 |
AbbVie
ABBV
|
+$773K |
| 4 |
MGM Resorts International
MGM
|
+$610K |
| 5 |
Kearny Financial
KRNY
|
+$521K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PCYC
PHARMACYCLICS INC
PCYC
|
+$1.79M |
| 2 |
Alnylam Pharmaceuticals
ALNY
|
+$1.34M |
| 3 |
General Motors Company
GM.WS.B
|
+$1.2M |
| 4 |
CELG
Celgene Corp
CELG
|
+$857K |
| 5 |
Taro Pharmaceutical Industries Ltd.
TARO
|
+$856K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 33.05% |
| 2 | Miscellaneous | 33% |
| 3 | Healthcare | 14.28% |
| 4 | Consumer Discretionary | 7.06% |
| 5 | Technology | 5.26% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
176
Diana Shipping
DSX
$357M
| $141K | 0.09% |
+28,607
| New | +$133K |
2015 Q2
0 quarters
|
|
177
Casella Waste Systems
CWST
$5.42B
| $140K | 0.09% |
25,000
| – | – |
2015 Q1
1 quarter
|
|
|
EBSB
178
DELISTED
Meridian Bancorp, Inc.
EBSB
| $134K | 0.08% |
10,000
| – | – |
2014 Q3
3 quarters
|
|
179
Teekay Tankers
TNK
$3.76B
| $132K | 0.08% |
2,500
-6,250
| -71% | -$336K |
2014 Q1
5 quarters
|
|
|
JCP
180
DELISTED
J.C. Penney Company, Inc.
JCP
| $127K | 0.08% |
15,000
-25,000
| -63% | -$216K |
2015 Q1
1 quarter
|
|
181
DELISTED
S&W Seed Co
SANW
| $122K | 0.08% |
1,316
| – | – |
2015 Q1
1 quarter
|
|
|
BBEP
182
DELISTED
BREITBURN ENERGY PARTNERS LP COM UNITS RPTNG LTD PRTNRSHIP
BBEP
| $119K | 0.07% |
+25,000
| New | +$145K |
2015 Q2
0 quarters
|
|
|
INFI
183
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
| $110K | 0.07% |
10,000
| – | – |
2014 Q2
4 quarters
|
|
184
FuelCell Energy
FCEL
$1.31B
| $107K | 0.07% |
25
| – | – |
2013 Q3
7 quarters
|
|
|
ELOS
185
DELISTED
Syneron Medical Ltd
ELOS
| $106K | 0.07% |
+10,000
| New | +$117K |
2015 Q2
0 quarters
|
|
|
GCVRZ
186
DELISTED
Sanofi Contingent Value Rights
GCVRZ
| $105K | 0.07% |
150,000
+50,000
| +50% | +$34.6K |
2013 Q2
8 quarters
|
|
|
MPVD
187
DELISTED
Mountain Province Diamonds Inc.
MPVD
| $104K | 0.06% |
+25,000
| New | +$100K |
2015 Q2
0 quarters
|
|
188
Cardiff Oncology
CRDF
$80.9M
| $102K | 0.06% |
+139
| New | +$98.6K |
2015 Q2
0 quarters
|
|
189
DELISTED
Bank Of America Corporation Ws B
BAC.WS.B
| $90K | 0.06% |
175,000
| – | – |
2013 Q2
8 quarters
|
|
190
Fortress Biotech
FBIO
$70.4M
| $84K | 0.05% |
1,667
| – | – |
2013 Q2
8 quarters
|
|
191
Rigel Pharmaceuticals
RIGL
$912M
| $80K | 0.05% |
2,500
| – | – |
2015 Q1
1 quarter
|
|
192
DELISTED
Christopher & Banks Corporation
CBK
| $80K | 0.05% |
+20,000
| New | +$110K |
2015 Q2
0 quarters
|
|
193
Pure Cycle
PCYO
$271M
| $78K | 0.05% |
15,000
| – | – |
2013 Q2
8 quarters
|
|
194
DELISTED
AMERICAN APPAREL INC COM
APP
| $74K | 0.05% |
150,000
| – | – |
2013 Q2
8 quarters
|
|
195
Apyx Medical
APYX
$112M
| $70K | 0.04% |
+25,000
| New | +$68.8K |
2015 Q2
0 quarters
|
|
|
IMNP
196
DELISTED
Immune Pharmaceuticals Inc.
IMNP
| $68K | 0.04% |
1,750
| – | – |
2014 Q3
3 quarters
|
|
197
Hovnanian Enterprises
HOV
$617M
| $67K | 0.04% |
1,000
| – | – |
2015 Q1
1 quarter
|
|
|
SFXE
198
DELISTED
SFX ENTERTAINMENT, INC COM
SFXE
| $67K | 0.04% |
15,000
| – | – |
2014 Q4
2 quarters
|
|
|
RNDY
199
DELISTED
ROUNDYS INC COM STK
RNDY
| $65K | 0.04% |
20,000
-5,000
| -20% | -$21.6K |
2014 Q4
2 quarters
|
|
200
DELISTED
Associated Banc-Corp Warrants
ASB.WS
| $64K | 0.04% |
18,400
-2,080
| -10% | -$6.04K |
2013 Q2
8 quarters
|
|
Similar funds
BC
PFM
SRP
CF
SA
WSA
SIG
VWM
E.E. Geduld's Q2 2015 Portfolio in Review
As of Q2 2015, E.E. Geduld held 361 positions worth $161M, up 7.3% from $150M the previous quarter. Its ten largest holdings account for 44% of the portfolio.
E.E. Geduld withdrew a net $5.71M in Q2 2015, closing 58 positions and reducing 55 holdings. Its most notable exit was PHARMACYCLICS INC, an estimated $1.79M position sold in full.
By sector, the portfolio is most concentrated in Financials at 33% of assets, down from 33% a quarter earlier, followed by Miscellaneous and Healthcare.
Against the trend, E.E. Geduld opened a new position in Capri Holdings worth $842K.
- E.E. Geduld's largest Q2 2015 buy was Capri Holdings: 20,000 shares worth $842K.
- E.E. Geduld added most to Blackstone Mortgage Trust in Q2 2015, an estimated $355K increase.
- E.E. Geduld's biggest Q2 2015 reduction was Alnylam Pharmaceuticals, cutting an estimated $1.34M.
- E.E. Geduld fully exited PHARMACYCLICS INC in Q2 2015, selling an estimated $1.79M.
- E.E. Geduld's ten largest holdings make up 44% of its $161M portfolio in Q2 2015.
- E.E. Geduld opened 80 new positions and closed 58 in Q2 2015.
- E.E. Geduld's portfolio value rose 7.3% quarter-over-quarter to $161M.
Based on E.E. Geduld's 13F filing for Q2 2015, filed 7 Aug 2015.